Aptamer Group (LON:APTA) Shares Up 11.3% – What’s Next?

Aptamer Group plc (LON:APTAGet Free Report) rose 11.3% during mid-day trading on Monday . The company traded as high as GBX 0.84 ($0.01) and last traded at GBX 0.84 ($0.01). Approximately 10,570,090 shares changed hands during trading, a decline of 41% from the average daily volume of 18,055,818 shares. The stock had previously closed at GBX 0.75 ($0.01).

Aptamer Group Price Performance

The firm’s fifty day simple moving average is GBX 0.79 and its 200 day simple moving average is GBX 0.49. The company has a market capitalization of £22.92 million, a PE ratio of -303.57 and a beta of -0.52.

Insider Transactions at Aptamer Group

In other Aptamer Group news, insider Adam Hargreaves bought 5,000,000 shares of the firm’s stock in a transaction dated Monday, September 8th. The shares were purchased at an average price of GBX 1 per share, for a total transaction of £50,000. Corporate insiders own 8.76% of the company’s stock.

Aptamer Group Company Profile

(Get Free Report)

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.

Read More

Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.